2020.6.18

AIST and RCMG Inc. signed an exclusive licensing agreement under which RCMG Inc. will receive an exclusive license to develop and commercialize diagnostics for non-small cell lung cancer (NSCLC).

2020.3.9

AIST and RCMG Inc. signed an exclusive licensing agreement under which RCMG Inc. will receive an exclusive license to develop and commercialize diagnostics for small cell lung cancer (SCLC).

2019.9.17

AIST and RCMG Inc. signed an exclusive licensing agreement under which RCMG Inc. will receive an exclusive license to develop and commercialize HBV diagnostics worldwide.

2019.7.11

RCMG Inc. was certified as the technology transfer company by National Institute of Advanced Industrial Science and Technology.

2019.2.12

RCMG Inc. started business in Tsukuba to develop IVD and provide drug response services.